UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): December 30, 2013

 

 

 

ELECTROMED, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Minnesota 001-34839 41-1732920
(State or Other Jurisdiction of
Incorporation)		 (Commission File Number) (I.R.S. Employer Identification
Number)

 

500 Sixth Avenue NW
New Prague, MN 56071

(Address of Principal Executive Offices)(Zip Code)

 

(952) 758-9299

(Registrant’s Telephone Number, Including Area Code)

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 
 

 

Item 8.01 Other Events.

 

On December 30, 2013, Electromed, Inc. (the “Company”) issued a press release announcing that it had received notification from the U.S. Food and Drug Administration that the Company’s next generation SmartVest® Airway Clearance System, the model SQLTM had been cleared to market. A copy of the Company’s press release is attached as Exhibit 99.1 and is incorporated herein by reference.

 

Item 9.01 Exhibits.

 

  (a) Financial statements: None.
     
  (b) Pro forma financial information: None.
     
  (c) Shell company transactions: None.
     
  (d) Exhibits:
     
    99.1 Press Release dated December 30, 2013.

 

 

 

 

 

 

 
 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Electromed, Inc.
     
Date: December 30, 2013 By /s/ Jeremy Brock
  Name:       Jeremy Brock
  Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

ELECTROMED, INC.

EXHIBIT INDEX TO FORM 8-K

 

 

Date of Report: Commission File No.:
December 30, 2013 001-34839

 

 

Exhibit    
Number   Description
99.1   Press Release dated December 30, 2013.